“Cash provided by financing activities for the first six months of 2025 was primarily the net proceeds from the issuance of our 2030 Convertible Notes of $977.5 million, which was partially offset by a $71.0 million purchase of capped call options associated w…”10-Q · Aug 4, 2026 ↗
Integer Holdings Corporation
ITGR
Market read
Integer Holdings Corporation's current read is isolated; its market group is not confirming.
The latest filing evidence is available. 0 of 14 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 1 directly disclosed connection is confirming.
- Revenue decreased 2.6% versus the comparable filing period.
- Lower production volumes reduced fixed-cost absorption and contributed to the gross-profit decline.
Invalidation: The isolated read changes if ITGR's group or a disclosed connection begins moving with it.
Research brief
The story so far
The latest filing evidence is available. 0 of 14 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 1 directly disclosed connection is confirming.
No thresholded supportive filing evidence is available yet.
- Revenue decreased 2.6% versus the comparable filing period.
- Operating margin fell 5.0 percentage points.
- Net income decreased 36.2% versus the comparable filing period.
- Lower production volumes reduced fixed-cost absorption and contributed to the gross-profit decline.
Company research
Understand the business, not just the ticker
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
- Which operating variable is changing?
- Is that change durable, cyclical or one-off?
- What evidence would disprove the current interpretation?
- Latest annual revenue changed +8.0% year over year.
- Operating cash flow covered net income at 1.91x in the latest annual period.
- Foreign exchange has repeated favorable evidence across 5 filings.
- Demand and volume has repeated favorable evidence across 3 filings.
- Product pipeline and R&D has repeated favorable evidence across 3 filings.
- Net margin changed -1.4 percentage points in the latest annual period.
- Credit and interest rates has repeated adverse evidence across 5 filings.
- P/E is 46% above the available filing-peer median; determine whether growth and quality justify the difference.
Price as of Sep 10, 2026
126.10Reported annual revenue and per-share history. This is accounting history, not a forecast.
What management says matters
Persistent and emerging business drivers
“Foreign currency exchange rate fluctuations increased C&V sales for the second quarter and first six months of 2026 by $0.3 million and $1.6 million, in comparison to the corresponding periods in 2025, primarily due to U.S.”10-Q · Aug 4, 2026 ↗
“The increase in C&V sales for 2025 was driven by strong growth from new product ramps in electrophysiology, contributions from acquisitions, and strong demand in neurovascular.”10-K · Feb 23, 2026 ↗
“The increase in C&V sales for 2025 was driven by strong growth from new product ramps in electrophysiology, contributions from acquisitions, and strong demand in neurovascular.”10-K · Feb 23, 2026 ↗
Valuation discipline
Descriptive valuation snapshot
Price/sales 2.4× · EV/sales 3.1×. Comparisons use only industry-matched filing peers.
Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.
Price action
How the market is pricing the story
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 12:10 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for ITGR. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Latest filing assessment
The latest filing shows material pressure
10-Q filed 2026-08-04 against the comparable filing from 2025-07-24.
Capital and cash conversion
Inventory built faster than revenue
Inventory growth exceeded revenue growth and inventory intensity increased.
- Capital spending YoY
- +5.5%
- Capital spending / revenue
- +5.2%
- Free-cash-flow margin
- +4.2%
- FCF margin change
- +0.8 pts
Capex, revenue, and operating cash flow are matched to the same reported duration. Reported accounting context, not a forecast or trading recommendation.
What improved
No thresholded improvement was identified.
What weakened
- Revenue decreased 2.6% versus the comparable filing period.
- Operating margin fell 5.0 percentage points.
- Net income decreased 36.2% versus the comparable filing period.
Filing receipts
“For additional information regarding legal proceedings pending against us, refer to Note 10, “Commitments and Contingencies,” of the Notes to Condensed Consolidated Financial Statements contained in Item 1 of this report. (b) Contract services expense increased primarily due to higher software costs from information technology enhancements.”
“Foreign currency exchange rate fluctuations increased C&V sales for the second quarter and first six months of 2026 by $0.3 million and $1.6 million, in comparison to the corresponding periods in 2025, primarily due to U.S. dollar fluctuations relative to the Euro.”
“Other Markets sales for the second quarter and first six months of 2026 decreased $7.6 million, or 43%, and $16.1 million or 45%, respectively, versus the comparable 2025 periods, primarily due to the Portable Medical Exit.”
Historical filing backfill generated after the original filing window. It is not part of Jodie's live track record.
Business ecosystem
The relationships behind ITGR
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depended on by
TELTE Connectivity plccompetitorNov 10, 2025 ▾
“The Industrial Solutions segment competes primarily against Amphenol, Hubbell, Carlisle Companies, Integer Holdings, Molex, Omron, JST, and Korea Electric Terminal (KET).”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 2 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
ITGR is currently a Follower in the organic co-movement group Mixed Sector Exposure. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.